Status:
COMPLETED
The Changes of Body Fat Distribution in Obese Patients With PCOS After LSG
Lead Sponsor:
Shanghai 10th People's Hospital
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Polycystic ovary syndrome (PCOS) is a common endocrine disorder, with a prevalence of 5% to 15% in premenopausal women. Patients with PCOS presents as abnormal menstruation, ovulation disorders and/or...
Detailed Description
This study consecutively enrolled 153 patients with obesity aged 18-45 years (83 with PCOS and 70 control patients) who underwent LSG from May 2013 to September 2020 at the Department of Endocrinology...
Eligibility Criteria
Inclusion
- Fmale aged 18- 45;
- Meet Rotterdam criteria(2003);
- body mass index (BMI)≥30 kg/m2
Exclusion
- Gender is male;
- Younger than 18 years old or older than 45 years old ;
- secondary obesity due to endocrine disorders;
- history of malignant tumors; 5）sever hepatic and renal disease;
- 6\) concurrent participation in other clinical trials; 7) sever endocrine and hereditary diseases; 8) mental illnesses that rendered them unable to provide informed consent; 9) patients declining to undergo complete study testing.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
153 Patients enrolled
Trial Details
Trial ID
NCT04690634
Start Date
May 1 2020
End Date
May 1 2021
Last Update
September 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Endocrinology, Shanghai Tenth People's Hospital
Shanghai, Shanghai Municipality, China, 200070